Shenzhen Delica Medical Equipment Co., Ltd. was established in 1998, Delica is the national high-tech enterprise which is engaged in high-tech medical equipment research and development manufacturing. Delica has been listed on the National Equities Exchange And Quotations in 2016 , of which stock code is 837573.
Delica is always focusing on neurology medical equipment product research and development, production, marketing and sales, especially in Transcranial Doppler (TCD), Multi-functional Vascular Ultrasound System (MVU), and Digital Electroencephalogram etc. Also as sales agent of the Netherlands FINAPRES company to sale Non-Invasive Blood Pressure Monitor (Continuous Non-Invasive Cardiac Blood Pressure Monitor, cNIBP).
Delica has won the Ministry of Science and Technology Torch Program project in 2011.
The project which is called "Digital brain blood flow reserve function diagnostic evaluation technology and its application research” has succeed jointly declared the Ministry of Science and Technology's 13th Five-year Plan by the First Hospital of Jilin University, Beijing Tiantan Hospital etc. with Delica in 2016.
Delica has independent intellectual property rights and It has 9 authorized invention patents at present. The company's quality system passed the German TUV, ISO13485: 2012 certification, and the main products also got the EU CE certification and the US FDA certification.
The National professional standard which is called "Transcranial Doppler Flow Analyzer YY / T0593-2015" was jointly revised by Wuhan National Ultrasonic Testing Center and Delica, and it began to implement in 2016.
The company's Transcranial Doppler series products reach the international leading level with CE and FDA certification, a large number of products were sold to the tertiary referral hospitals and were exported to Europe and the United States. Nearly 10,000 domestic users in China, and the international market share is in the top two. The market share among the best in 2016 which included China, the United States, South Korea, the Netherlands, Hong Kong and other countries and regions.
Delica products are becoming more and more extensive in application of academic research, and the number of published academic articles which had used Delica equipments from domestic and abroad are also increasing.
Delica has established a long-term cooperative research relationship with Chinese Academy of Sciences, Aerospace Center Hospital, The Hong Kong Polytechnic University, The Chinese University of Hong Kong, Jilin University, Capital Medical University, Peking University, University of Cambridge, University of California, University of Southern Queensland, National Central University, South China University of Technology, and the Netherlands FINAPRES company etc.
The company's product strategy is for global users, and research and development the advanced medical equipment and provide medical data applications, providing for patients with individual miniaturization, portable equipment at the same time.
The world has entered the era of brain science at present, Delica owned brain research which needs of high-end EEG, cerebral blood flow, continuous noninvasive blood pressure etc. core technology combination. Delica will contribute to its own strength for the research and application of heart and brain science!